Member Info for jock47

The link attached suggests third party mobile payments in China are expected to reach $12 trillion by next year.
Myanmar is a new market and similarly, the mobile payments will be a huge number. The market hasn’t got the importance of today’s RNS with our Tencent relationship.
It soon will.

Plenty happening now. I know the Stanford team plus Incanthera plus MAP.
This share is going to soar very soon.

If my calculation is correct , IMM will own 23% of Incanthera by end of this year, plus our own Lucozor MAP under way. I am beginning to see IMM as a strong buy.

I have read and reread the latest RNS . Chairman’s quote..... we remain focussed on achieving the full regulatory approval of lupozor,
There is a lot of speculative comment going on here. The RNS seems to say ... This will take time, be patient, we are still on the case. Thus I cannot comprehend the huge share price decline The key is , are we traders or investors. Traders may be concerned but investors should be delighted at the buy opportunity.

It is an important first step.

These are the chairman’s words. This is a clear buy signal and what I have been waiting for.

Did IMM continue to give the drug to patients who want to continue the treatment after the trial? Many were pleading to continue because it works for them with no side effect. Eventually this will be an approved winning drug, just got to get through the statistical protocol.

The company has an obligation to update the market before opening on Monday. The nomad will insist on this under market abuse regulations(MAR).
I believe it will either be positive news or a further extension date. Either way I am relaxed . Medium term this share is a star performer.

No where does it say that Ebioss don’t have funds. The standstill is until 3 August to tidy up conditions subsequent, nothing to do with funding. Dealer55 is incorrect.

Are you sure?? Receivables rising..very odd . Director sale one week ago. Binary options revenue now zero. 51% of Bet90, marketing spend needed. Very little cash. I would say overbought!! Where is the revenue coming from. Terrible critique on internet.

Something is beginning to stir now. 40 trades this morning and new comment on speaking to pharmaceuticals . When the herd return this will rocket. I am a realist. This company is so oversold it is hard to believe...just look at the rest of their portfolio even without lupus.

I agree Geeforce. The client base of the company is blue chip and top quality. To have a market cap of £12.00m only at this point seems to me to be derisory. This share has an exciting time ahead.

Early interim rise is my bet. This share is undervalued, it is extraordinary. ...on fundamentals, balance sheet, market position and takeover target we should be several multiples of current price.

I agree that it was a huge overreaction to the recent RNS. The drug will be reformulated and needs some tweaks. It will be produced , just need to work out optimum algorithm.

Takeover chat could be starting to develop. If so.....what a bargain price!!!!!!!!!!

Elegance, you are correct. Let�s kick a lot of the nonsense on these bb�s in to the long grass. This share is ,in my view, now one of the best recovery plays on the market. It is massively oversold.

Peel Hunt research note, 8p target. Some way to go.

Chairman is highly encouraged. So should we be. I hope this wipes out some of the nonsensical posts that have appeared on here recently. IMM at these levels is a great recovery stock.

With a market cap of �20.0m this seems to me to still be a major bargain. It is likely with these views that this will attract an international media corporation. �20.0m to them is petty cash. Take your own view but with 4.6B views in April, way ahead of three months ago, this should command more like �200m.

With this reach and influence , BBSN has got to be one of the most undervalued shares on AIM. I would anticipate that an international corporation may well want to buy their market share and , if so, it would be at many times their market capitalisation of ,believe it or not, only �5.00m. What a great RNS.